Jun 03, 2021 / 05:00PM GMT
Matthew Christopher Phipps - William Blair & Company L.L.C., Research Division - Senior Biotechnology Research Analyst
Hi, my name is Matt Phipps. I'm a Research Analyst here at William Blair covering Incyte. And just before we get things kicked off, I do have to say, please visit williamblair.com for a list of any disclosures or conflicts of interest. And I'm happy to have with us Christiana Stamoulis, the Chief Financial Officer; and Steve -- Steven Stein, Chief Medical Officer to talk about kind of the growth of Jakafi and the expanding business at Incyte.
And since we only have 30 minutes here, I'm going to jump right into questions and talking about the company.
Questions and Answers:
Matthew Christopher Phipps - William Blair & Company L.L.C., Research Division - Senior Biotechnology Research AnalystSo Christiana, I wonder if you could start us off, talk about Jakafi, a bit of a lighter first quarter, but still maintaining full year guidance.
So how do you feel now about the COVID-19 impact and being able to hit that
Trustpilot
